Researchers Mapped Mitochondrial DNA Variants in Blood Cells
A new computational tool enables the analysis of mitochondrial DNA heteroplasmy using existing single-cell sequencing data.
Updated on Oct. 13, 2026 in Biotech
Live Poll
Do you believe new genetic research will significantly improve our ability to treat chronic human diseases?
Researchers have developed a computational framework called scMOCHA that identifies mitochondrial DNA heteroplasmy—the presence of more than one type of organelle genome within a cell—using standard single-cell RNA sequencing data. This research-stage tool allows scientists to track these variants across hematopoietic, or blood-forming, cell types.
Why it matters
Understanding how mitochondrial DNA variants influence human disease has been hampered by a lack of granular data on their distribution across different tissues. This framework provides a method to study these mutations and their links to oxidative stress and inflammation.
The framework integrates mitochondrial DNA genotypes with matched single-cell nuclear transcriptomes and structural modeling to resolve heteroplasmy. It specifically highlights variants driven by replication errors and oxidative stress compared to baseline cellular states.
The details
scMOCHA functions by parsing existing single-cell RNA sequencing (scRNA-seq)—a method to analyze the gene expression of individual cells—to isolate mitochondrial DNA signals. It maps these signals alongside nuclear transcriptomes to determine how somatic mutations (genetic changes acquired after conception) distribute within specific hematopoietic lineages. The research notes that while replication errors lead to homoplasmic variants, oxidative stress is the primary driver of heteroplasmic mutations within these cell populations.
Timeline
October 13, 2026: The research findings were published.
The Tech Race
This development follows a pattern set by the Human Cell Atlas by providing new methods to map genetic diversity within individual human cells. It expands the diagnostic toolkit for single-cell genomics, which is currently focused on linking nuclear expression profiles to specific disease phenotypes.
This framework is currently a research-stage tool for scientists and bioinformaticians. It enables re-analysis of publicly available hematopoietic datasets to identify previously hidden links between mitochondrial DNA mutations and inflammatory diseases.
The takeaway
The study highlights that mitochondrial variants are highly tissue-specific and influenced by metabolic stress. Future research should track how these variants manifest in non-hematopoietic tissues using similar scRNA-seq integration techniques.
Further reading
For broader trends in single-cell genomic analysis, visit our Biotech section.
More information
Access the full study of mitochondrial genome variants to view the methodology and results.
Source note: This article includes information reported by Biorxiv.
Live Poll
Do you believe new genetic research will significantly improve our ability to treat chronic human diseases?
